This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Michael Campbell: Innovator in Cancer Treatment
Introduction
Michael Campbell is a notable inventor based in Woodside, California. He has made significant contributions to the field of cancer treatment, particularly through his innovative research on tyrosine kinase receptor antagonists.
Latest Patents
One of his key patents is titled "Tyrosine kinase receptor antagonists and methods of treatment for breast cancer." This patent discloses a method of treatment whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may include an injectable carrier and two or more tyrosine kinase receptor inhibitors, which may be nordihydroguaiarectic acid (NDGA) and doxorubicin. This innovative approach aims to enhance the effectiveness of breast cancer treatments.
Career Highlights
Michael Campbell is affiliated with the University of California, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from breast cancer.
Collaborations
Some of his notable coworkers include Ira D Goldfine and John Kerner, who have collaborated with him on various research projects aimed at developing effective cancer treatments.
Conclusion
Michael Campbell's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile